baber/WOPTO huggingface dataset:
Patent ES-2203280-B2 (ES)
Title: Sistema para la realizacion de ensayos de carga distribuida sobre membranas.
Inventor: BALLESTER MUNOZ FRANCISCO
IPC: G01N3/10
Filed: 2001-05-04
Granted: 2005-02-16
Abstract: El sistema para la realización de dos tipos de ensayos de carga distribuida sobre membranas. Consta de un marco (2) en el que se sujeta la muestra de la membrana (1) en todo su perímetro. Este marco se coloca sobre unos apoyos rígidos (5). Por la parte interior de la membrana se hacen pasar dos barras de acero con rosca (4) y se anclan en el suelo (8). Sobre la membrana (1) se coloca una placa de sobrecarga (6) y una placa de reparto para la aplicación de la carga sobre la membrana (1). Esta placa permite el paso de las barras ancladas. Las barras se hacen pasar por el interior de un cilindro hidráulico (7) y se pone un tope (9) en la parte superior. Los cilindros hidráulicos (7) aplican la fuerza sobre la placa.
Patent ES-2364469-B2 (ES)
Title: Transductor basado en redes de difracción en fibra óptica.
Inventor: LOPEZ HIGUERA JOSE MIGUEL
IPC: G01L1/24
Filed: 2010-09-07
Granted: 2012-05-03
Abstract: Un transductor (20, 20a, 20b) que comprende: una pletina (25) que comprende una primera red de difracción en fibra óptica (26) situada en su superficie superior y una segunda red de difracción en fibra óptica (27) situada en su superficie inferior, donde dichas primera y segunda redes de difracción en fibra óptica (26, 27) están configuradas para traducir un cambio de curvatura en dicha pletina (25) en un desplazamiento de la longitud de onda correspondiente a cada red de difracción en fibra óptica (26, 27). El transductor (20, 20a, 20b) comprende además una primera pieza (21, 21b) y una segunda pieza (22, 22a, 22b) unidas entre sí a través de al menos un eje (23, 24), estando dicha pletina (25) fijada a al menos uno de los lados de una de las piezas (21, 21b; 22, 22a, 22b), estando el transductor (20, 20a, 20b) configurado para cambiar la curvatura de dicha pletina (25) mediante un cambio del ángulo que forman dichas primera pieza (21, 21b) y segunda pieza (22, 22a, 22b).
Patent ES-2422178-B2 (ES)
Title: Procedimiento de visión artificial para la detección de espermatozoides con colas en ovillo
Inventor: ALEGRE GUTIERREZ ENRIQUE
IPC: G06T7/60
Filed: 2012-03-06
Granted: 2014-12-04
Abstract: Procedimiento de visión artificial para la detección de espermatozoides con colas en ovillo.#Se describe un procedimiento automatizado de clasificación de semen basado en la captura de imágenes digitales de la muestra a clasificar. Dicho procedimiento hace uso de técnicas de manipulación de las imágenes digitales capturadas para detectar espermatozoides con colas en ovillo.
Patent AU-2001212402-B2 (AU)
Title: Tag library compounds, compositions, kits and methods of use
Inventor: SALINMI-MOOSAVI HUSSEIN
IPC: C07H19/10
Filed: 2000-10-27
Granted: 2004-11-04
Abstract: Methods and compositions are provided for detecting target molecules, e.g. DNA sequences, particularly single nucleotide polymorphisms, using a pair of nucleotide sequences, a primer and a snp detection sequence, where the snp detection sequence binds downstream from the primer to the target DNA in the direction of primer extension, or ligands and receptors. The methods employ e-tags comprising a mobility-identifying region joined to a detectable label and a target-binding region. The result of the binding of the target-binding region to the target is to have a bond cleaved in the starting material with the production of a detectable product with a different mobility from the starting material, where the different e-tags can be separated and detected
Patent AU-2001235009-B2 (AU)
Title: Drug delivery apparatus
Inventor: DENYER JOHN STANLEY HAROLD
IPC: A61M11/06
Filed: 2001-02-12
Granted: 2004-10-07
Abstract: A drug delivery apparatus comprising a drug delivery device for selectively delivering drug-laden air or air not laden with the drug; a sensor (4) for monitoring the breathing pattern of a patient; a controller (24) arranged to control the drug delivery device to deliver drug-laden air in pulses which begin when the patient is monitored by the sensor (4) to begin inhalation, the pulses having a duration which is adjusted by the controller (24) on the basis of the monitored breathing pattern of the patient; a feedback indicator (16) which indicates to a patient whether the monitored breathing pattern is effective for inhaling drug-laden air or not; a dose calculator (25) which calculates the dose delivered to the patient; and an indicator (17) which indicates to the patient when a desired dose has been delivered, whereby the apparatus is configured to deliver the full amount of the desired dose in at least 80 % of treatments.
Patent AU-2001265391-B2 (AU)
Title: Intravascular stent with increasing coating retaining capacity
Inventor: JANG G DAVID
IPC: A61F2/82
Filed: 2001-06-05
Granted: 2006-04-27
Abstract: The present invention relates to an expandable stent, comprising a tubular structure including an outer surface positionable adjacent to a vessel wall, an inner surface facing a lumen of a body passageway, a plurality of substantially straight expansion struts (16), connector struts (18) and cells (24), the tubular structure having a first diameter which permits intraluminal delivery of the tubular structure into the body passageway having a lumen, and a second expanded and deformed diameter upon the application from the interior of the tubular member of a radially, outwardly extending force, the cells having areas which enlarge upon expansion of the stent, characterized by a plurality of cavities (26, 40) formed in the stent providing as reservoirs of a coating substance, wherein the cavities extend from the outer surface of the stent through the inner surface of the stent, and wherein the cavities are distributed in an even pattern.
Patent AU-2002215117-B2 (AU)
Title: M. Tuberculosis chaperonin 60.1 and uses thereof
Inventor: COATES ANTHONY ROBERT MILNES
IPC: A61P17/02
Filed: 2001-11-16
Granted: 2005-05-19
Abstract: The invention relates to pharmaceutical compositions of an approx 60kDa polypeptide (or its encoding nucleic acid molecules) or functionally equivalent molecules or fragments thereof from  Mycobacterium tuberculosis  or related prokaryotes in the treatment of non-cancerous pathological conditions such as autoimmune and allergic disorders.
Patent AU-2002220679-B2 (AU)
Title: Cosmetic method of treating skin
Inventor: GREEN MARTIN RICHARD
IPC: A61Q19/00
Filed: 2001-11-02
Granted: 2006-05-18
Abstract: A cosmetic method for treating aged, wrinkled and/or photodamaged skin is provided through topical application of a composition which comprises 8-prenylnaringenin.
Patent AU-2002306618-B2 (AU)
Title: Substituted diarylureas as stimulators for Fas-mediated apoptosis
Inventor: VILLAR HUGO O
IPC: C07C273/16
Filed: 2002-03-01
Granted: 2006-11-09
Abstract: Substituted diarylureas, pharmaceutical compositions containing them, and their use for stimulating Fas-mediated apoptosis. The compounds, as single stereoisomers or mixtures of stereoisomers, their pharmaceutically acceptable salts, and pharmaceutical compositions containing them, are useful in methods of treating autoimmune diseases, infectious diseases, and malignancies.
Patent AU-2002319033-B2 (AU)
Title: Methods for increasing in vivo efficacy of oligonucleotides and inhibiting inflammation in mammals
Inventor: ALLAM MUSTAPHA
IPC: A61P31/12
Filed: 2002-07-08
Granted: 2008-01-10
Abstract: The invention relates to the use of nucleotide substitutes for increasing the in vivo efficacy of nucleic acid molecules and also for inhibiting inflammation in mammals. More particularly, the present invention relates to the use of 2′6′ diaminopurine (DAP) and analogs thereof per se in anti-inflammatory compositions, and also for preparing nucleic acid molecules having an increased in vivo physiological efficiency and a reduced toxicity as compared to conventional oligos. The invention is particularly useful for the preparation of antisense oligonucleotides for treating pulmonary/respiratory diseases such as cystic fibrosis, asthma, chronic bronchitis, chronic obstructive lung disease, eosinophilic bronchitis, allergies, allergic rhinitis, pulmonary fibrosis, adult respiratory distress syndrome, sinusitis, respiratory syncytial virus or other viral respiratory tract infection and cancer.
Patent AU-2002336664-B2 (AU)
Title: Thermally enhanced soil decontamination method
Inventor: ROUFFIGNAC ERIC PIERRE DE
IPC: B09C1/06
Filed: 2002-10-24
Granted: 2007-09-13
Abstract: A method is provided to remove contaminants from contaminated soil. The method may include withdrawing vapors from a vapor extraction well, estimating the amount of water vapor removed from the contaminated soil in the vapors being withdrawn from the vapor extraction well, and applying heat to the contaminated soil from a plurality of heater wells at a rate not greater than that which would vaporize the estimated amount of water vapor. The permeability of the soil may thereby increase by the application of heat. Six or more heat injection wells may be provided for each vapor extraction well, and the heat injection wells may be placed and energized in a regular pattern around the vapor extraction well, which may include multiple rings of heaters around each vapor extraction well.
Patent AU-2002359154-B2 (AU)
Title: Method for producing a surface structure on an implant, and such an implant
Inventor: HALL JAN
IPC: A61F2/30
Filed: 2002-12-18
Granted: 2008-04-03
Abstract: A surface structure is produced on an outer surface of an implant or a fixture and forms a base structure in a range of implants related to different types and qualities of jaw bone. During production of the surface, parts of a turning tool are placed against the implant or against a blank which is intended to form the implant. The parts and/or the implant are assigned controls which give rise to mutual displacements between the parts and the implant so that the parts follow a substantially spiral trajectory along the outer surface. By means of said controls, a long wave pattern is formed with successive peaks and with through lying between these. In this connection, a through can be arranged adjacent to the outer parts of an existing thread. The controls are chosen so as to produce through depths in the range of 25 to 250 μm, preferably 50 to 200 μm. The invention also relates to an implant which bas the same character as the implant produced by the method.
Patent AU-2003235171-B2 (AU)
Title: Variable Length Coding Method and Variable Length Decoding Method
Inventor: HAGAI MAKOTO
IPC: H04N19/196
Filed: 2003-04-16
Granted: 2007-12-20
Abstract: The present invention is a variable length coding method for coding coefficients in each block which are obtained by performing frequency transformation on picture data of a moving picture per block having a predetermined size, and comprises:a coefficient scanning step of scanning the coefficients in the block in a predetermined order; and a coding step of coding the coefficients scanned in the coefficient scanning step into variable length codes in a predetermined order by switching a plurality of tables to be used for coding. Here, a direction of switching between the tables may be one-directional. Also, the coding may be non-arithmetic coding.
Patent AU-2003245807-B2 (AU)
Title: Cigarette dispenser for self-service shops
Inventor: KNUPFER ROBERT
IPC: A47F1/06
Filed: 2003-04-25
Granted: 2008-03-20
Abstract: The invention relates to a cigarette dispenser (1) for self-service shops, comprising a device (7) for holding and propelling cigarette packets (10), in addition to a device (3) for holding and propelling cigarette cartons (5), said cigarette dispenser (1) being closed by at least one locking grille (14) that can be optionally driven by an electric motor. The invention is characterised in that the device (3) for holding the cigarette cartons (5) is located in a lower position than the device (7) for holding the cigarette packets (10) and that both devices (3, 7) are configured and arranged in such a way that in order to remove the cigarette packets (10) and the cigarette cartons (5), the former (10) are propelled in a horizontal or oblique direction and the latter (5) are propelled in a vertical direction.
Patent AU-2003247634-B2 (AU)
Title: Stent-graft fastening
Inventor: MILLS EDWARD GRAHAM
IPC: A61F2/06
Filed: 2003-06-24
Granted: 2008-07-17
Abstract: A fastening for fixing an exposed stent (20) to a graft material (1). At least two spaced apart fastenings (7, 8) are used, each fastening has at least one turn and preferably two turns of an elongate flexible fibre through the graft material and around a portion of the stent. Each fastening has a knot (9) which is at least two thumb knots and preferably four thumb knots.
Patent AU-2004205701-B2 (AU)
Title: A rotational moulding machine
Inventor: WOOD RICHARD ROY
IPC: B29C41/06
Filed: 2004-01-23
Granted: 2009-03-05
Abstract: A rotational moulding machine includes three mould manipulator arrangements and a rotatable carrousel on which the manipulators are mounted for indexed rotation between heating, cooling and mould loading stations. Each manipulator includes a rectangular frame, stub axles on the frame which are rotatable in supports on the carousel on a first axis, mould locating element in the frame which is rotatable on a second axis normal to the first and devices for manipulating a mould in the frame on both axes. The machine includes a crane beam over the carrousel which overlies the heating and cooling station positions on the carrousel, a heating chamber, a wall enclosure, and a crane for lowering the heating chamber and wall enclosure over manipulators on the carrousel at the heating and cooling stations and for lifting them clear of the manipulators to enable them to be indexed to the next station.
Patent AU-2004258789-B2 (AU)
Title: Process for preparing concentrated milk protein ingredient and processed cheese made therefrom
Inventor: CARR ALISTAIR JAMES
IPC: A23J3/10
Filed: 2004-07-21
Granted: 2010-02-18
Abstract: Process for preparing a concentrated milk protein ingredient comprising the steps of: providing a membrane retentate solution having kappa-casein milk protein, adjusting the divalent ion content of said protein solution to a predetermined level at which no gel is formed after treatment with milk clotting enzyme, adding a food grade milk clotting enzyme under conditions where kappa-casein is converted to para-kappa casein while remaining in solution, terminating the conversion by removal or inactivation of the enzyme and concentrating said solution. The resultant milk protein concentrate ingredient is used in the production of cheese.
Patent AU-2004288868-B2 (AU)
Title: Substrate provided with a dressing
Inventor: SCHAEFER PHILIPP
IPC: C14C11/00
Filed: 2004-11-15
Granted: 2010-02-18
Abstract: To endow a velourlike carrier (7), which has a finely fibrous surface, in particular a grain leather having a buffed topside or a synthetic velour material, and has been provided with a dressing (1) which has a grain texture on its face side the dressing (1) consisting of a consolidated polymeric dispersion and being produced separately on a substrate having a textured surface corresponding to the grain texture, with the requisite properties in terms of softness and abrasion resistance, but particularly in terms of air and water vapor permeability, the dressing (1) has capillaries (11) which extend throughout its entire thickness, which everywhere is substantially the same, and is bonded to the carrier (7) via a thin bonding layer (12) formed of a consolidated polymeric dispersion.
Patent AU-2004317889-B2 (AU)
Title: Systems and methods for immobilization having prompted movement
Inventor: SMITH PATRICK W
IPC: F41H13/00
Filed: 2004-10-07
Granted: 2007-10-04
Abstract: Systems and method for immobilizing a target such as a human or animal with a stimulus signal coupled to the target via numerous electrodes select particular electrodes to use for the stimulus signal. Subsets of electrodes may be tested by applying a test signal and monitoring the energy or charge delivered during a prescribed time. If the delivered energy or charge using a particular subset of electrodes as indicated by monitoring test pulse amplitude suitably compares to a limit, then the particular subset is selected for applying the stimulus signal. A first stimulus signal may be applied to a first subset of electrodes to prompt movement of the target toward an electrode that, when better coupled to the target as a consequence of movement of the target will provide a more effective subset of electrodes for further stimulus. For example, a projectile with closely spaced electrodes may stimulate a burning sensation to attract the target to impale the target's hand on a rear facing electrode of the projectile. Use of the rear facing electrode and one or more of the closely spaced electrodes may provide a more effective stimulus circuit through tissue of the target.
Patent AU-2005213420-B2 (AU)
Title: Lithium secondary cell with high charge and discharge rate capability
Inventor: CHU ANDREW C
IPC: H01M4/583
Filed: 2005-02-07
Granted: 2010-10-21
Abstract: A high capacity, high charge rate lithium secondary cell includes a high capacity lithium-containing positive electrode in electronic contact with a positive electrode current collector, said current collector in electrical connection with an external circuit, a high capacity negative electrode in electronic contact with a negative electrode current collector, said current collector in electrical connection with an external circuit, a separator positioned between and in ionic contact with the cathode and the anode, and an electrolyte in ionic contact with the positive and negative electrodes, wherein the total area specific impedance for the cell and the relative area specific impedances for the positive and negative electrodes are such that, during charging at greater than or equal to 4 C, the negative electrode potential is above the potential of metallic lithium.
Patent AU-2005235459-B2 (AU)
Title: Device for administering an injectable product with a secured dosing device
Inventor: MOSER ULRICH
IPC: A61M5/24
Filed: 2005-04-19
Granted: 2009-10-08
Abstract: A device for administering an injectable product including a housing with a reservoir for the product, a delivery device, which can be displaced out of a release position and into an activating position and, from the activating position, executes a delivery movement via which a set product dose is discharged from the reservoir, and a dosing device that, for setting a product dose, can execute a dosing movement in dosing positions predetermined by detent engagement when the delivery device occupies the release position, wherein the delivery device, when in the activating position and when moving into the activating position, is coupled to the dosing device via a blocking engagement which prevents the dosing device in the respectively set dosing position from executing dosing movements.
Patent AU-2005247962-B2 (AU)
Title: Industrial gear unit
Inventor: LEIMAANN DIRK-OLAF
IPC: F16H57/04
Filed: 2005-05-27
Granted: 2010-07-22
Abstract: An industrial gear unit including a housing ( 14 ) which contains lubricated gear components, a water coolant device ( 1 ) which defines, at least in part, a fluid chamber ( 3 ) and fluid inlet ( 4 ) and outlet parts, and a retention element ( 32 ) which secures the water coolant device to the housing, the water coolant device defining a contact surface ( 5,6 ) and the housing providing an external contact surface against which the contact surface of the water coolant device is secured by the retention element.
Patent AU-2005280704-B2 (AU)
Title: Perorally administrable antimicrobial composition
Inventor: CHICHERIN DMITRY SERGEEVICH
IPC: A61K45/08
Filed: 2005-08-25
Granted: 2010-10-07
Abstract: The invention relates to medicine and the chemical and pharmaceutical industry, in particular to antibiotic preparative forms. The inventive antimicrobial composition contains antibiotic selected from a group of lincosamides, broad-spectrum penicillins, cephalosporins, macrolides, tetracyclines, and lactulose at the active component ratio of 1:1-1:100. The mean particle size of lactulose ranges from 100 nm to 200 µm. Said composition is also embeddable in a solid state and in the form of a syrup or a suspension. When applicable, pharmaceutically acceptable excipients are added into the composition in such a way that it takes a form acceptable for peroral administration.
Patent AU-2006226179-B2 (AU)
Title: Apparatus and control system for generating power from wave energy
Inventor: ROBERT THOMSON ALLAN
IPC: F03B13/18
Filed: 2006-03-15
Granted: 2011-09-01
Abstract: The present invention relates to a wave energy conversion device (1) , for use in relatively shallow water, which has a base portion (2) for anchoring to the bed of a body of water (6) and an upstanding flap portion (8) pivotally connected (12) to the base portion. The flap portion is biased to the vertical and oscillates, backwards and forwards about the vertical in response to wave motion acting on its faces. Power extraction means extract energy from the movement of the flap portion. When the base portion (2) is anchored to the bed of a body of water (6) with the flap portion (8) facing the wave motion, the base portion (2) and the flap portion (8) extend vertically through at least the entire depth of the water, to present a substantially continuous surface to the wave motion throughout the full depth of water from the wave crest to the sea bed. A plurality of devices can be interconnected to form one system. The distance between the plurality of flaps is dependent on the wavelenght.
Patent AU-2006230231-B2 (AU)
Title: Methods and apparatus for a manual vascular compression device
Inventor: FINKIELSZTEIN MARCO
IPC: A61B17/08
Filed: 2006-03-29
Granted: 2012-08-02
Abstract: A vascular compression apparatus and method for applying pressure onto an area of a patient generally including a blood vessel and a wound site, such as a blood vessel puncture, after a cannulated procedure for the purpose of controlling bleeding and achieving hemostasis. The vascular compression apparatus includes a handle, a shaft and a pad. The shaft extends generally downward from the center of the bottom side of the handle. The pad is connected generally off-center of its top side to the bottom end of the shaft. The bottom side of the pad is convex to allow the vascular compression device to be rocked back and forth. In use, the pad is generally placed proximal to the catheter insertion site and over the blood vessel containing the catheter. The device is rocked proximally to control blood flow while removing the catheter. After the catheter is removed from the puncture site, the device is rocked distally to the puncture site , where pressure is applied until hemostasis is achieved.
Patent AU-2006239929-B2 (AU)
Title: Dipeptidyl peptidase-IV inhibitors
Inventor: CHRISTOPH STEENECK
IPC: C07D207/16
Filed: 2006-04-21
Granted: 2011-11-03
Abstract: The present invention relates generally to pyrrolidine and thiazolidine DPP-IV inhibitor compounds. The present invention also provides synthetic methods for preparation of such compounds, methods of inhibiting DPP-IV using such compounds and pharmaceutical formulations containing them for treatment of DPP-IV mediated diseases, in particular, Type-2 diabetes.